A PHASE IV MULTICENTER, OPEN-LABEL STUDY EVALUATING B CELL LEVELS IN INFANTS POTENTIALLY EXPOSED TO OCRELIZUMAB DURING PREGNANCY - THE MINORE STUDY

Is this Study for You?

Let's Get Started!

Details
Age

Child to Adult

Type of Study

Outcomes Research

Locations

Outpatient CTRC
University of Colorado Hospital

Principal Investigator
Photograph of Anna Shah,  MD

Anna Shah, MD

Study ID

Protocol Number: 22-0386

More information available at ClinicalTrials.gov: NCT04998812

Is this Study for You?

Let's Get Started!

Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers